The global prevalence of 537 million affected in the age group of 2079 years in 2021 will rise to 783 million in 2045, with the lowest increase in incidence in Europe (13%) and the highest in the African countries south of the Sahara (134%) ( Obesity, defined as a body mass index above 30 kg/m 2 , is also increasingly prevalent worldwide and has become a challenge to the various healthcare systems and societies
Jumping ahead eliminates the tolerance-building advantage that makes microdosing work
In vitro assays show relatively balanced GLP-1 and glucagon receptor activity, with stronger GIP receptor potency reported in some assay systems
Once-weekly GLP-1 medications like semaglutide (Ozempic) and dulaglutide (Trulicity) offer greater convenience with less frequent injections, while once-daily options like liraglutide (Victoza) may provide more consistent day-to-day effects
Patients interested in participating in clinical trials can search for opportunities through NIHR Be Part of Research (bepartofresearch.nihr.ac.uk) or speak with their GP about eligibility
Food and Drug Administration in 2021, continues to generate buzz 3 years later